Skip to main content

Maa Oori Polimera 2: A Telugu Horror Movie That Will Leave You Spellbound

Maa Oori Polimera 2, a Telugu horror movie released on November 3, 2023, is the sequel to the critically acclaimed film Maa Oori Polimera. Directed by Dr. Anil Vishwanath, the film stars Satyam Rajesh, Kamakshi Bhaskarla, Getup Srinu, Baladitya, Chitram Seenu, Ravi Varma, Rakendu Mouli, and Sahiti Dasari in pivotal roles. Synopsis The film is set in the superstitious village of Jasthipalli, where a series of mysterious deaths have been occurring. Jangaiah (Baladitya), a police constable, goes missing, and his elder brother Komuraiah (Satyam Rajesh), who is suspected to be involved in black magic, is presumed dead. The arrival of the new SI, Ravindra Naik (Rakendu Mouli), brings the focus on Jangaiah's disappearance and Komuraiah's death. As he tries to unravel the mystery surrounding the brothers, shocking details are uncovered. Komuraiah's actions are directly linked to the closed Lord Vishnu temple and the treasure beneath it. How is black magic involved, and what's t...
Post a Comment

A Possible Greenlight From FDA for First-Ever COVID-19 Treatment Pill Availability In This December 2021

A Possible Greenlight From FDA for First-Ever COVID-19 Treatment Pill Availability In This December 2021

FDA is going to discuss the potential authorization of a very promising drug on December 30 for the clinical treatment of covid-19 coronavirus disease. This drug will most probably be available for its first public usage in December.

Formation of A Game Changer Coalition For the "Holy Grail" of Treatments: 

Merck and Ridgeback Biotherapeutics, two biotechnology companies have joined together for a joint venture of production of an oral antiviral drug for the treatment of COVID-19 Coronavirus disease. This miracle drug was invented and initially researched by the professors and sentients of the drug innovation company associated with Emory University in Atlanta, Georgia, United States of America. The name of the potentially first-ever Covid-19 treatment drug is Molnupiravir (development codes MK-4482 and EIDD-2801).

The biotechnology company Ridgeback Biotherapeutics has got the license of this drug Molnupiravir, from Emory University for the production and later improvements and further refinement cycles. Ridgeback Biotherapeutics is now partnered with another pharmaceutical giant Merck & Co. for the further development and pharmaceutical manufacturing of this drug for mass production and distribution.

A Possible Greenlight From FDA at The End of This Year: 

Merck & Co. along with its COVID-19 pill development partner, Ridgeback Biotherapeutics has requested the Food and Drug Administration FDA for their authorization of this first-ever pill for COVID-19 treatment. FDA officials will meet on November 30 to discuss the viability of this COVID-19 pill based on the strict FDA guidelines for standards of patient safety and its treatment efficiency on COVID-19 patient treatment. If the drug meets the standard and guidelines essential for authorization, FDA will likely give a green light for the clinical utilization of the drug for general public COVID-10 Coronavirus treatment in the December of this year.

A Miraculous Drug In These Grim Times: 

This COVID-19 treatment pill has successfully passed all the three trial phases essential for any drug authorization for its clinical usage and also its utilization for the general public. This Covid-19 pill has successfully treated almost half of the patients including severely ill and hospitalized patients. Especially phase three drug trials for this COVID-19 pill was so successful that further investigations for this drug safety and effectiveness were stopped on October 2021 and the companies behind this pill forwarded their request for FDA approval for immediate usage of this drug in mild to severely ill patients of Covid-19 coronavirus diseases.  

The winters are coming again and there will be a surge of COVID-19 patients in hospitals and intensive care units. This COVID-19 pill will fill a great void for the treatment of severely ill patients, especially the unvaccinated patients who have more potential to acquire the disease than vaccinated people. This pill will stop the virus reproduction and hinder the virus making its host patient more severely ill and in turn, this pill will help as a barrier for further spreading of COVID-19. Therefore this COVID-19 pill is also considered as the ''holy grail' of Covid-19 Coronavirus disease treatments. 

Merck's COVID-19 Pill Eligibility Criteria: 

It seems that there will be limitations to the availability of this drug. This COVID-19 drug company previously allowed the participation of over age 60 severely ill patients with underlying health issues like heart diseases, diabetes, and obesity. Such patients had five days of developing symptoms of COVID-19 Coronavirus disease. 

All three essential drug trial phases were administered and researched on only unvaccinated patients. Therefore, this drug will be only recommended to be used on unvaccinated patients at first clinical usage for the general public. Most probably, Vaccinated patients will not be recommended in breakthrough usage, at the beginning of this Covid-19 treatment pill.  

This COVID-19 Pill is not the replacement of the benefits which a person has after getting the vaccination of COVID-19. This drug will work as a treatment for the COVID-19 Coronavirus disease. 

COVID-10 vaccinations are the only way a person gets the highest chances of avoiding the COVID-19 Coronavirus disease and severe complications including chances of death.

This COVID-19 Pill Is An Actual Treatment of the Disease And More Importantly, This pill Fits The Bill Associated With This pill Costs:

Right now there is only FDA approved drug for mild to severely ill patients which is not a treatment of the COVID-19 Coronavirus disease, which is antiviral Remdesivir. 

The Second option which FDA authorized to be used in the patents will be mild or moderate systems, are the usage of monoclonal antibodies drugs. These monoclonal antibody drugs are only available in the form of injections or infusions. Both forms of these antibody drugs are only used via medical officers or nurses in hospitals and clinics. This antibody treatment is extremely costly, costing the government around $2,000 per dosage.

The low-cost development of the Covid-19 treatment drug is essential for its general mass production and global availability as an affordable treatment for the COVID-19 Coronavirus disease. This COVID-19 pill is a cheaper alternative as compared with all the drugs available in the market for shortening the recovery time from mild to severe COVId-19 systems. 

Merck's COVID-19 treatment pill is named ''Molnupiravir''. ''Molnupiravir'' is an oral antiviral drug. This pill cost only $700 per treatment and one treatment package consists of 40 pills. These COVID-19 treatment pills will be used on four campuses two times a day for five days. Merck's COVID-19 treatment pill ''Molnupiravir'' will be available as a prescription drug at general pharmacies.

Merck's COVID-19 Pill Availability: 

It is now confirmed that the government of the United States of America has ordered the manufacturer for the treatment of at least 1.7 million highly vulnerable people. Merck will make 10 million treatment courses for the global usage of the COVID-19 pill. Well-known Indian drug manufacturers are also in talks with Merck for the development and distribution of this COVID-19 treatment in low and middle-income countries in Asia and Africa. Treatment costs in these low and middle-income countries will vary which will, in turn, depend upon the development and distribution costs associated with these countries.

The Course of Action of Merck's Covid-19 Treatment Pill: 

Merck's COVID-19 treatment pill ''Molnupiravir'' belongs to a special kind of antiviral drug called nucleosides. Nucleoside drugs can block a virus replication inside the cell by producing enough mutations or changes in the genetic information of the parts of the virus which help in virus replication. A virus is almost unable to replicate or produce its offspring without the presence of such reproductive parts. 

What are the Side Effects of Merck's COVID-19 treatment pill ''Molnupiravir'':

This Covid-19 treatment pill is safe to be used as the number of cases of minor side effects shown by participants of both groups (patients who have received Placebo & the patients who have received the actual drug pill) participated in the first, second, and the third phases of drug trials. This means that this COVID-19 treatment pill ''Molnupiravir'' has almost no adverse side effects associated with its intended usage.

Image Courtesy:
Image numbers below show the sequences of their appearance in this article. 
Image Number One: Photo by Christina Victoria Craft on Unsplash
Image Number Two: Photo by CDC on Unsplash
Image Number Three: Photo by National Cancer Institute on Unspllash 
Image Number Four: Photo by CDC on Unsplash
Image Number Five: Photo by National Cancer Institute on Unspla

Comments

Post a Comment

Popular posts from this blog

The USA Has At Least 120,000 Industrial Areas Containing Toxic “Forever Chemicals’’

Almost 120,000 industrial areas have been discovered in the USA which are homes to toxic chemicals. This category of these toxic chemicals is called "forever chemicals'' as they are very harmful to the health of the general public and responsible for various life-threatening diseases including cancer.  These ''forever chemicals'' consist of materials with perfluoroalkyl and polyfluoroalkyl substances which are also abbreviated as (PFAS). It is estimated that almost 100,000 per year deaths in the USA are associated with these harmful, toxic ''forever chemicals''.  This extensive research, carried out by the United States Environmental Project Agency (EPA), points out the states of the USA with more industrial areas and facilities associated with these toxic chemicals. Colorado tops the chart with almost 21,400 industrial areas, California state comes in second with at least 13,000 facilities and Oklahoma state has only 12,000 such industrial ...
Post a Comment
Read more

VanMoof Has Become The World Most Funded e-Bike Company After Acquiring Almost $128 Million

VanMoof is an Amsterdam-based electric bike company. VanMoof was founded in 2009 by two Dutch brothers, Taco Carlier and Ties Carlier. The company has grown its bike community to 200,000 electric bike riding communities by their strong efforts and innovations in this e-bike market. VanMoof is now one of the fastest-growing vehicle production companies in the EU. The company has a strong market in some European countries but they want to go global by setting an ambitious target of production and delivery of 10 million e-Bikes in the upcoming 5 years. Asia-based private equity firm Hillhouse is also playing its major role in this round of funding for the VanMoof company.  At first, the company was successful in raising a $40 million investment back in mid-2020. This year in 2021, VanMoof company easily raised almost $128 million. The strong funding around the production of one person only driving vehicles like e-Bikes is also due to the post-Covid world where lots of world population...
Post a Comment
Read more

TSMC To Reduce Carbon Footprint to Net Zero Emission By 2050

It Is A Big Bet Of TSMC But Chip Industry Is In A Paradox OF More Chip Demand & More Natural Resources Usage:  TSMC which is the world-leading semiconductor manufacturing foundry has decided to reduce its greenhouse gas emissions to zero by 2050 for environmental sustainability and for saving the Ozone layer. The company established its Net Zero carbon Project back in 2020. It successfully implemented the guidelines and achieved the net zero emissions target in its global offices already.  It is always very clear that human activities helped in emissions of increased quantities of greenhouse gases which are comprised of man-made fluorinated or synthetic HFCs (hydrofluorocarbons) gases along with higher quantities of Carbon dioxide, methane, nitrous oxide, and synthetically produced fluorinated gases.  World's Chip Fabrication Paradox.  TSMC is the major computer chip manufacturing foundry for most of the leading technology brands of the world like NVidia, MediaTe...
Post a Comment
Read more